Cutler Group’s Bionano Genomics BNGO Stock Holding History

Cutler Group’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-106	Closed	-$6K	–	5332
2021 Q4	$6K	Sell	106 -2	-2%	-$5.35K	﹤0.01%	4033
2021 Q3	$10K	Sell	108 -170	-61%	-$595K	﹤0.01%	3904
2021 Q2	$80K	Buy	278 +115	+71%	+$454K	﹤0.01%	2061
2021 Q1	$51K	Buy	+163	New	+$919K	﹤0.01%	2368

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cutler Group's BNGO Position: Q4 2023 in Review

Cutler Group sold out of Bionano Genomics (BNGO) in Q4 2023, closing a stake of 9 shares — an estimated $1K sold.

Cutler Group first reported a position in BNGO in Q1 2021 and held it in 11 quarters. The position peaked at $1.29M in Q1 2021. 62 funds tracked by Wall St. Rank hold BNGO as of Q4 2023.

Cutler Group reported no remaining Bionano Genomics position as of Q4 2023 after selling out during the quarter.
Cutler Group sold 9 Bionano Genomics shares in Q4 2023, an estimated $1K.
Cutler Group first reported a position in Bionano Genomics in Q1 2021 and held it in 11 quarters.
Cutler Group's Bionano Genomics position peaked at $1.29M in Q1 2021.
62 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.